Pakistan secured $629.5 million in commercial agreements and $800 million in MoUs at a recent Pakistan-China Pharmaceutical B2B Conference. The deals, spanning local vaccine production, API manufacturing, and medical devices, aim to transform Pakistan's pharmaceutical industry, attract foreign investment, and reduce import dependence. This initiative is a key part of government efforts to strengthen the economy and improve its investment potential. Such substantial foreign investment and import substitution could improve Pakistan's balance of payments, potentially easing pressure on the USD/PKR exchange rate.
بحوالہ / Source: www.brecorder.com